Department of Neurobiology and Developmental Sciences, College of Medicine, University of Arkansas for Medical Sciences, 4301 W. Markham St., Slot #826, Little Rock, AR 72205-7199, USA.
Hear Res. 2013 Jan;295(1-2):30-7. doi: 10.1016/j.heares.2012.03.010. Epub 2012 Apr 1.
This manuscript reports on findings of three open-label, pilot studies and it reviews studies using rTMS as a maintenance treatment for any disorder. The first pilot study examined whether a patient's original treatment response to 1 Hz rTMS over temporal cortex could be replicated by stimulating a homologous region of the opposite hemisphere. The second study examined whether a patient's response to 1 Hz rTMS could be replicated by applying 10 Hz rTMS over the same treatment site. The third study applied a 3-day course of maintenance rTMS, either at 1 or 10 Hz, when subjects indicated that the benefit of their last course of treatment was waning. Patients with bilateral subjective tinnitus of at least 6 months duration were recruited from a prior, sham controlled study with treatment crossover that applied 1 Hz rTMS over temporal cortex. Both treatment responders and non-responders were recruited. Results indicated, first, that the original treatment response, both positive and negative, is replicated after stimulating a homologous region of the opposite hemisphere; second, patients respond similarly to 1 and 10 Hz stimulation of the same treatment site (an exception was one patient who initially failed 1 Hz stimulation but responded positively to 10 Hz stimulation); and, third, maintenance rTMS had a sustained and additive benefit for tinnitus among treatment responders. Conclusions are that rTMS-induced effects on tinnitus are neither hemisphere specific nor frequency dependent; although, different frequencies of rTMS may have greater potency for a given subject. Maintenance treatment is a well tolerated approach with demonstrated feasibility for managing chronic tinnitus in persons who respond positively to an initial course of treatment.
这篇手稿报告了三项开放标签、试点研究的结果,并回顾了使用 rTMS 作为任何障碍维持治疗的研究。第一项试点研究检验了患者对颞叶皮层 1 Hz rTMS 的原始治疗反应是否可以通过刺激对侧半球的同源区域来复制。第二项研究检验了患者对 1 Hz rTMS 的反应是否可以通过在同一治疗部位施加 10 Hz rTMS 来复制。第三项研究在患者表示其最后一次治疗的益处正在减弱时,应用了为期 3 天的维持 rTMS(1 或 10 Hz)。招募了来自先前的、假对照研究的双侧主观性耳鸣至少 6 个月的患者,这些患者接受了颞叶皮层的 1 Hz rTMS 治疗交叉。招募了治疗反应者和非反应者。结果表明,首先,刺激对侧半球的同源区域后,原始的治疗反应(阳性和阴性)均可复制;其次,患者对同一治疗部位的 1 和 10 Hz 刺激的反应相似(一个例外是一个最初对 1 Hz 刺激无反应但对 10 Hz 刺激有阳性反应的患者);第三,维持 rTMS 对治疗反应者的耳鸣有持续和累加的益处。结论是 rTMS 对耳鸣的影响既不是半球特异性的,也不是频率依赖性的;尽管不同频率的 rTMS 对特定个体可能具有更大的效力。维持治疗是一种耐受良好的方法,已证明其在对初始治疗有反应的患者中管理慢性耳鸣的可行性。